The above findings demonstrate for the first time CRFR1 hypermethylation as a hallmark of early CRC status, which is remarkably diminished as the disease progresses to more aggressive phenotypes, reaching the almost normal levels. This evidence concerns the gene CRHR1 and colorectal carcinoma.